Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Benjamin Gloria
Observed name:
Gloria., Benjamin C.
Institutions:
Olivia Newton-John Cancer Wellness & Research Centre,
Olivia Newton-John Cancer Research Institute
Observed institutions:
Ludwig Cancer Research,
La Trobe University,
Ludwig Cancer Research,
Olivia Newton-John Cancer Wellness & Research Centre,
Olivia Newton-John Cancer Research Institute
ORCID:
0009-0002-6101-525X
Observed ORCID:
0009-0002-6101-525X
OpenAlex ID:
A5041124535
Development of monoclonal anti-PDGF-CC antibodies as tools for investigating human tissue expression and for blocking PDGF-CC induced PDGFRα signalling in vivo
2018
·
Hong Li
, Manuel Zeitelhofer
, et al.
·
PLoS ONE
·
16
PDF
Global conformational changes in IgG-Fc upon mutation of the FcRn-binding site are not associated with altered antibody-dependent effector functions
2018
·
Ingrid J.G. Burvenich
, William Farrugia
, et al.
·
Biochemical Journal
·
4
Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025
·
Sagun Parakh
, Nhi Huynh
, et al.
·
Molecular Cancer Therapeutics
·
2
Evaluation of an online biomass probe to monitor cell growth and cell death
2011
·
Angelo Perani
, Benjamin Gloria
, et al.
·
BMC Proceedings
·
2
PDF
Characterisation of mAb104 Antibody–Drug Conjugates Targeting a Tumour-Selective HER2 Epitope
2025
·
Sagun Parakh
, Nhi Huynh
, et al.
·
Cancers
·
1
PDF
Data from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025
·
Sagun Parakh
, Nhi Huynh
, et al.
·
1
Impact on product quality of high productive GS-CHO cell lines
2011
·
Angelo Perani
, Benjamin Gloria
, et al.
·
BMC Proceedings
·
1
PDF
Supplementary Table 2 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025
·
Sagun Parakh
, Nhi Huynh
, et al.
Figure S7 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025
·
Sagun Parakh
, Nhi Huynh
, et al.
Supplementary Data from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025
·
Sagun Parakh
, Nhi Huynh
, et al.
Figure S2 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025
·
Sagun Parakh
, Nhi Huynh
, et al.
Figure S4 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025
·
Sagun Parakh
, Nhi Huynh
, et al.
Figure S8 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025
·
Sagun Parakh
, Nhi Huynh
, et al.
Figure S5 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025
·
Sagun Parakh
, Nhi Huynh
, et al.
Figure S6 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025
·
Sagun Parakh
, Nhi Huynh
, et al.
Supplementary Table 1 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025
·
Sagun Parakh
, Nhi Huynh
, et al.
Figure S3 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025
·
Sagun Parakh
, Nhi Huynh
, et al.
Figure S1 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025
·
Sagun Parakh
, Nhi Huynh
, et al.
Abstract 5318: Optimizing pharmacokinetics and targeting properties of recombinant anti-Lewis Y antibody hu3S193 in A431 tumor-bearing mice
2011
·
Ingrid J. Burvenich
, F T. Lee
, et al.
·
Cancer Research
Optimizing pharmacokinetics and targeting properties of recombinant anti-Lewis Y antibody hu3S193 in A431 tumor bearing mice
2011
·
Ingrid J.G. Burvenich
, FT Lee
, et al.
·
Cancer Research
Show more works
View as search
Works count:
22
Citation count:
27
H-index:
2
I10-index:
1
Year
Topic
Type